News summary

AliveCor launches KardiaACCESS for Medicare beneficiaries

Source: Longevity Technology • Published: 17 Sept 2026, 14:36

Summarized by Masters of Longevity from Longevity Technology.

KardiaACCESS is the subject of an article about a Medicare-focused, clinician-guided care program using connected devices; expect a look at program design and patient access.

AliveCor launches KardiaACCESS for Medicare beneficiaries
Key Takeaways
  • AliveCor launched KardiaACCESS as a 10-year program under the CMS ACCESS Model focused on cardio-kidney-metabolic outcomes.
  • The program is claimed to be available to eligible Original Medicare Part B beneficiaries with no out-of-pocket cost.
  • KardiaACCESS supplies connected devices and emphasizes clinician-guided, outcome-aligned management of blood pressure and blood sugar.
Read the full article at Longevity Technology

Continue exploring

Recommended MoL Picks

MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?MoL PickThe Next Obesity-Drug Race Is About What Weight You LoseRegeneron’s myostatin and activin A antibodies point to a sharper question for the GLP-1 era: not whether people can lose more weight, but whether medicine can preserve the tissue that makes weight loss healthier.